|1.||Park, Seung-Yeol: 3 articles (05/2012 - 01/2010)|
|2.||Terao, Naoko: 2 articles (06/2015 - 02/2013)|
|3.||Miyoshi, Eiji: 2 articles (06/2015 - 02/2013)|
|4.||Kamada, Yoshihiro: 2 articles (06/2015 - 02/2013)|
|5.||Kim, Ji-Yeon: 2 articles (05/2012 - 01/2010)|
|6.||Kim, Jin-Man: 2 articles (05/2012 - 01/2010)|
|7.||Regnier, Fred E: 2 articles (01/2011 - 02/2009)|
|8.||Kim, Jung-Hoe: 2 articles (01/2010 - 01/2010)|
|9.||Yoon, Seon-Joo: 2 articles (01/2010 - 01/2010)|
|10.||Nakayama, Kotarosumitomo: 1 article (06/2015)|
|1.||Prostatic Neoplasms (Prostate Cancer)
05/15/2012 - "Aleuria aurantia lectin reactivity with cancer β-Hp was much higher than in the other two study groups. "
05/15/1995 - "In previous studies we showed that the fucose-specific lectin, lotus tetragonolobus, extracted high amounts of API in cancer when patients were unresponsive to treatment. "
06/15/2015 - "We previously established a Fuc-Hpt lectin-antibody assay using Aleuria aurantia lectin (AAL), and applied this to diagnose several diseases, including various cancers. "
01/01/1995 - "Increased fucosylation is a common finding, and the fucose-specific lectin, lotus tetragonolobus, can be used to differentiate different diseases (eg inflammatory conditions, liver diseases), and to monitor disease activity in cancer. "
01/01/2010 - "Blotting index of serum beta-haptoglobin with Aleuria aurantia lectin (AAL) was clearly higher for cancer patients than for healthy subjects. "
|3.||Liver Cirrhosis (Hepatic Cirrhosis)
09/01/2012 - "In this study, tandem lectin affinity chromatography using aleuria aurantia lectin (AAL) and wheat germ agglutinin (WGA) was processed to purify both fucosylated and sialylated serum glycoproteins from 27 liver cirrhosis (LC) and 27 early HCC patients, in which 122 glycoproteins were finally screened out by liquid chromatography-tandem mass spectrometry (LC-MSMS). "
01/01/1994 - "Accordingly, the analysis of Aleuria aurantia lectin-reactive ChE is clinically useful for differentiating liver cirrhosis from chronic hepatitis and to identify high risk groups for hepatocellular carcinomas, i.e., cirrhotic patients in Child's A grade."
03/01/1999 - "Discrimination of liver cirrhosis from chronic hepatitis by measuring the ratio of Aleuria aurantia lectin-reactive serum cholinesterase to immunoreactive protein."
12/15/1995 - "Enzyme-linked immunosorbent assay (ELISA) for Aleuria aurantia lectin-reactive serum cholinesterase to differentiate liver cirrhosis and chronic hepatitis."
03/01/1999 - "We have previously reported that Aleuria aurantia lectin (AAL)-reactive serum cholinesterase (ChE) activity increases in liver cirrhosis (LC) and hepatocellular carcinoma (HCC) compared with chronic hepatitis (CH) and normal controls (NC), and measurement of AAL-reactive ChE activity is useful in discriminating LC from CH. "
|4.||Mevalonate Kinase Deficiency
09/01/1995 - "Crossed affinoimmunoelectrophoresis using concanavalin A and Aleuria aurantia lectin as diantennary glycan- and fucose-specific affinocomponents, respectively, was applied to study changes in the concentration and glycosylation of the acute phase protein alpha 1-acid glycoprotein (AGP) in sera obtained from patients with hyperimmunoglobulinemia D and periodic fever syndrome. "
|5.||Chronic Hepatitis B
|5.||Acute-Phase Proteins (Acute-Phase Protein)
|1.||Drug Therapy (Chemotherapy)